Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Lymphomagenic Roles of MYC, E2F and Mir-150-5p in Plasmablastic Lymphoma: Therapeutic and Prognostic Implications

Blood (2022) 140 (Supplement 1): 9266–9268.

https://doi.org/10.1182/blood-2022-168552

Published: 2022

Journal Articles

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Josep Muncunill, MSc, Maria Joao Baptista, PhD PharmD, Agueda Hernandez-Rodriguez, PhD, Judith Dalmau, PhD, Gustavo Tapia, MD PhD, Olga Garcia, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Javier Martinez-Picado, PhD, Josep-Maria Ribera, MD, Evarist Feliu, MD PhD, Jose-Luis Mate, MD PhD, Jose Tomas Navarro, MD PhD

Blood (2017) 130 (Supplement 1): 4004.

https://doi.org/10.1182/blood.V130.Suppl_1.4004.4004

Published: 2017

Journal Articles

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Maria Joao Baptista, PharmD, PhD, Gustavo Tapia, MD, Ana-Maria Muñoz-Marmol, PhD, Olga Garcia, MD, Josep Muncunill, MSc, Maria-Jose Terol, MD PhD, Eva González-Barca, MD PhD, Pilar Miralles, MD PhD, Ferran Vall-Llovera, MD, Mariano Provencio, MD PhD, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD, Jose-Tomas Navarro, MD PhD

Blood (2015) 126 (23): 3874.

https://doi.org/10.1182/blood.V126.23.3874.3874

Published: 2015

Journal Articles

Advanced Stage Hodgkin’s Lymphoma Has More Aggressive Characteristics but Similar Outcome in HIV-Infected Than in HIV-Negative Patients in the Combination Antiretroviral Therapy Era

Jose-Tomas Navarro, MD PhD, Marc Sorigue, MD, Blanca Xicoy, MD PhD, Olga Garcia, Maria Joao Baptista, PhD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD

Blood (2014) 124 (21): 4435.

https://doi.org/10.1182/blood.V124.21.4435.4435

Published: 2014

Journal Articles

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Jose-Tomas Navarro, MD, PhD, Maria Joao Baptista, PhD, Alejandra Martinez-Trillos, MD, Gustavo Tapia, MD, Jose Angel Hernandez-Rivas, MD, PhD, Olga Garcia, Anna Muñoz-Marmol, PhD, Juan-Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Jose-Luis Mate, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2013) 122 (21): 5083.

https://doi.org/10.1182/blood.V122.21.5083.5083

Published: 2013

Journal Articles

Applicability of Different Immunohistochemistry Algorithms to Assess Gene Expression Profile In Patients with Diffuse Large B-Cell Lymphoma

Blood (2010) 116 (21): 4134.

https://doi.org/10.1182/blood.V116.21.4134.4134

Published: 2010

Journal Articles

Folicular and Diffuse Large B Cell Lymphoma Can Be Distinguished by 1H -Magnetic Resonance Spectroscopy.

Carolina Sanz, PhD, Ignasi Barba, PhD, Gustavo Tapia, MD, Jose-Luis Mate, MD, Angels Barbera, Josep-Maria Ribera, PhD, Aurelio Ariza, PhD, David Garcia-Dorado, PhD, Albert Oriol, MD

Blood (2007) 110 (11): 3584.

https://doi.org/10.1182/blood.V110.11.3584.3584

Published: 2007

Journal Articles

Comparison of Immunohystochemical (IHC) Expression Profile and Prognosis in 98 Patients with Diffuse Large B Cell Non-Hodgkin’s Lymphoma (DLBCL) with and without Human Immunodeficiency Virus (HIV) Infection.

Blanca Xicoy, MD, Josep-Maria Ribera, PhD, Mireia Morgades, MD, Jose-Luis Mate, PhD, Gustavo Tapia, MD, Jose-Tomas Navarro, PhD, Tatiana Ruiz, MD, Aurelio Ariza, PhD, Evarist Feliu, PhD

Blood (2007) 110 (11): 4403.

https://doi.org/10.1182/blood.V110.11.4403.4403

Published: 2007

Journal Articles

The History of 34 Errors Identified in 874 Patients Analyzed at Weekly Clinical-Pathological Meetings in Two Institutions over 22 Years (1982–2004).

Evarist Feliu, MD, Blanca Xicoy, MD, Maria Rozman, MD, Fuensanta Milla, MD, Josep-Lluis Aguilar, MD, Jose-Luis Mate, MD, Jose-Lluis Vives, MD, Josep-Maria Ribera, MD, Elias Campo, MD, Jordi Junca, MD, Neus Villamor, MD, Isabel Granada, MD, Dolors Colomer, MD, Jose-Tomas Navarro, MD, Ciril Rozman, MD

Blood (2004) 104 (11): 5287.

https://doi.org/10.1182/blood.V104.11.5287.5287

Published: 2004

NARROW

Lymphomagenic Roles of MYC, E2F and Mir-150-5p in Plasmablastic Lymphoma: Therapeutic and Prognostic Implications

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

Advanced Stage Hodgkin’s Lymphoma Has More Aggressive Characteristics but Similar Outcome in HIV-Infected Than in HIV-Negative Patients in the Combination Antiretroviral Therapy Era

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Applicability of Different Immunohistochemistry Algorithms to Assess Gene Expression Profile In Patients with Diffuse Large B-Cell Lymphoma

Folicular and Diffuse Large B Cell Lymphoma Can Be Distinguished by 1H -Magnetic Resonance Spectroscopy.

Comparison of Immunohystochemical (IHC) Expression Profile and Prognosis in 98 Patients with Diffuse Large B Cell Non-Hodgkin’s Lymphoma (DLBCL) with and without Human Immunodeficiency Virus (HIV) Infection.

The History of 34 Errors Identified in 874 Patients Analyzed at Weekly Clinical-Pathological Meetings in Two Institutions over 22 Years (1982–2004).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only